Skip to main content
. 2017 Jan 16;17:57. doi: 10.1186/s12885-016-3032-4

Table 9.

Adjusted Relative Risk of VTE due to Cisplatin based Chemotherapy

β coefficient SE (β) Relative Risk 95% CI for RR
Cisplatin based chemotherapy 1.2 0.37 3.32 1.6–6.8

adjusted for ECOG, Khorana risk score, GCSF, presence of CVC and gender-log likelihood =471.38